Saira Sultan - Board Member
Saira Sultan has represented corporate, nonprofit, and government interests in the legislative and regulatory health policy arena for more than 20 years in Washington, D.C. She has had repeated success in designing business solutions by identifying and creating advocacy opportunities and translating them into strategic legislative and regulatory results. Saira brings a decade of experience working with market access, health outcomes, and commercial teams in pharmaceutical companies, including Pfizer and Sanofi. Saira is an experienced project management lead for large cross-functional efforts at Medtronic, Pfizer, Sanofi, and more.
Focusing on areas such as oncology, vaccines, and specialty products in sickle cell and arthritis, Saira has worked extensively with CMS, FDA, and Capitol Hill. Her insight and skill in working cross-functionally in a corporate environment, as well as with advocacy organizations and key trade associations serve her clients well. Saira’s leadership at the Association of Community Cancer Centers (ACCC) allowed her to build strong relationships with the oncology community and gain insights into the evolution of oncology care. She continues to work in close collaboration with many oncology organizations, identifying emerging trends that have led to repeated success in tackling coverage, coding and payment of marketed and pipeline Part B and D products. The Government Affairs and Policy team at ACCC, under Saira’s direction, raised significant revenue, improved the Association’s profile, as she became a sought-after speaker on oncology policy issues. Complementing her ten years in pharmaceuticals, Saira’s time at Medtronic gives her an in-depth understanding of the unique needs of the device industry. Representing Medtronic at a time when CMS was completely revamping device reimbursement in hospital outpatient departments, gave her the opportunity to work in close collaboration with CMS and key stakeholders. Saira built a successful coalition of varied stakeholders that ensured reimbursement for Class III devices reflecting their value to patients.
Additionally, Saira brings House and Senate experience, including work on the Ways and Means Committee, and roles as senior legislative counsel for Senator Mike DeWine (R-OH) and Chief Counsel to one of the Senate Healthcare Subcommittees. She handled all healthcare issues under the Senate HELP Committee’s jurisdiction, including extensive negotiations with FDA and industry on the Balanced Budget Act of 1997 and the first reauthorization of the Prescription Drug User Fee Act. She spearheaded passage of the first Better Pharmaceuticals for Children.
Saira holds a JD from the University of Virginia in Charlottesville, VA